Active Motif acquires Amaryllis Nucleics

By The Science Advisory Board staff writers

January 28, 2022 -- Active Motif has purchased Amaryllis Nucleics, a startup focused on proprietary RNA sequencing methods.

Amaryllis provides Active Motif with a streamlined, low-cost library preparation method to perform high-efficiency RNA sequencing using its intellectual property associated with 3' digital gene expression, said Active Motif. The technology uses novel synthesis chemistry, which the company said is twice as fast from RNA to library prep compared to other methods, is less expensive, and shows greater than 99% strand specificity.

Amaryllis' service business and its 3' DGE RNA Library Prep Kit will be integrated into the Active Motif portfolio, according to the firm.

Financial details of the acquisition were not disclosed.

Active Motif is focused on bringing epigenetics more deeply into precision medicine.

Copyright © 2022

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.